Citadel Advisors
NVX

Citadel Advisors’s NOVONIX NVX Stock Holding History

Citadel Advisors’s Portfolio NVX Stock Details NVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,390
Closed -$92.4K – 14496
2026
Q1 		$92.4K Buy
13,390
+8,250
+161% +$80.2K ﹤0.01% 12084
2025
Q4 		$51.9K Buy
+5,140
New +$72.9K ﹤0.01% 12017
2025
Q2 		– Sell
-450
Closed -$5.17K – 14278
2025
Q1 		$5.17K Buy
+450
New +$6.35K ﹤0.01% 13835
2024
Q3 		– Sell
-10
Closed -$179 – 14925
2024
Q2 		$179 Sell
10
-1,120
-99% -$25K ﹤0.01% 14076
2024
Q1 		$25.9K Buy
+1,130
New +$22.8K ﹤0.01% 12823

Other funds holding NVX

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $2.38B AUM 88.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Personalized Indexing Management
Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $984M AUM 34.75% 1-Year Est. Return

Citadel Advisors's NVX Position: Q2 2026 in Review

Citadel Advisors reduced its NOVONIX (NVX) stake by 55% in Q2 2026, selling an estimated $97.1K and leaving 12,051 shares worth $55.4K. The position accounts for ﹤0.01% of the portfolio, ranked #13073.

Citadel Advisors first reported a position in NVX in Q1 2024 and has held it in 7 quarters since. The position peaked at $184K in Q1 2026. 25 funds tracked by Wall St. Rank hold NVX as of Q2 2026.

  • Citadel Advisors held 12,051 shares of NOVONIX worth $55.4K as of Q2 2026.
  • Citadel Advisors sold 14,589 NOVONIX shares in Q2 2026, an estimated $97.1K.
  • NOVONIX made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13073 holding.
  • Citadel Advisors first reported a position in NOVONIX in Q1 2024 and has held it in 7 quarters since.
  • Citadel Advisors's NOVONIX position peaked at $184K in Q1 2026.
  • 25 funds tracked by Wall St. Rank held NOVONIX as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.